Bristol-Myers Squibb (BMY) FY2023 results: revenue $45.0 billion, down 2.5% on the year
Bristol-Myers Squibb Co. (BMY) reported revenue of $45.0 billion for fiscal 2023, the year ended 31 December 2023, down 2.5% on the year before. Net income was $8.0 billion, up 26.8%, and diluted earnings per share $3.86. The figures are the company's own, from the 10-K it filed with the SEC on 13 February 2024.
Revenue
$45.0 billion
-2.5% on the year
FY2016FY2023
Operating margin
18.8%
16.7% a year earlier
FY2016FY2023
Net income
$8.0 billion
+26.8% on the year
FY2016FY2023
Diluted EPS
$3.86
+30.8% on the year
FY2016FY2023
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2023
FY2022
FY2021
On the year
Last 8 years
Operating cash flow
13,860
13,066
16,207
+6.1%
Capital expenditure
1,209
1,118
973
+8.1%
Free cash flow
12,651
11,948
15,234
+5.9%
Free cash flow margin
28.1%
25.9%
32.8%
Cash from investing
-2,295
-1,062
-538
Cash from financing
-9,416
-16,962
-16,224
Depreciation and amortisation
9,760
10,276
10,686
-5.0%
Share-based compensation
518
457
583
+13.3%
Buybacks
5,155
8,001
6,287
-35.6%
Dividends paid
4,744
4,634
4,396
+2.4%
Dividend per share
$2.31
$2.19
$2.01
+5.5%
Diluted shares, weighted
2,078m
2,146m
2,245m
-3.2%
Balance sheet
$ million
FY2023
FY2022
FY2021
On the year
Last 8 years
Shareholders' equity
29,430
31,061
35,946
-5.3%
Non-controlling interest
55.0
57.0
60.0
-3.5%
Short-term borrowings
n/a
n/a
4,948
Debt
39,772
39,320
44,369
+1.1%
Operating lease liabilities
1,530
1,261
874
+21.3%
Other liabilities
24,372
25,121
23,117
-3.0%
Total liabilities and equity
95,159
96,820
109,314
-1.7%
Fixed assets
6,646
6,255
6,049
+6.3%
Goodwill
21,169
21,149
20,502
+0.1%
Intangible assets
27,072
35,859
42,527
-24.5%
Investments
1,180
130
2,987
+807.7%
Cash and equivalents
11,464
9,123
13,979
+25.7%
Receivables
8,882
8,151
7,979
+9.0%
Inventory
2,662
2,339
2,095
+13.8%
Other assets
16,084
13,814
13,196
+16.4%
Total assets
95,159
96,820
109,314
-1.7%
10-K for the year ended 31 December 2023, filed 13 February 2024: the filing.